Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Ma..

lumikha ng bagong artikulo

10 sa

Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Overview, Growth Analysis, Trends and Forecast By 2032 | #obesity drugs # incretin therapies # GLP-1 agonists # weight loss drugs # dual-acting obesity treatment

Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Overview, Growth Analysis, Trends and Forecast By 2032

The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period

Gusto

Magkomento

Ibahagi

10 sa

Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Overview, Growth Analysis, Trends and Forecast By 2032

Wika